Rane Pharmaceutical Inc.
$144,000.00 CAD
≈ 22 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2026-2027
- Agreement period
- June 1, 2026 – May 31, 2027
- Reference
- nrc-cnrc:172-2026-2027-Q1-1043904
Published purpose
Rane Pharmaceutical is developing novel small molecule therapy to treat drug resistant Non-Small Cell Lung Cancer (NSCLC). Over 30,000 Canadians are diagnosed annually with this type of lung cancer. Conventional treatments face drug resistance which remains a major barrier with no current secondary options. Having validated novel compounds, Firm intends to develop a therapeutic that addresses a massive unmet need of cancer drug resistance.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 10, 2026 from open.canada.ca Grants & Contributions